HAEMONETICS CORP MASS - NOTE 2.500% 6/0

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Debt / NOTE 2.500% 6/0
Number of holders
49
Total 13F principal, excl. options
693M
Principal change
+693M
Total reported value, excl. options
$691M
Value change
+$691M
Number of buys
48
Price
$1.00

Significant Holders of HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q2 2025

49 filings reported holding 405024AD2 - HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q2 2025.
HAEMONETICS CORP MASS - NOTE 2.500% 6/0 has 49 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $693M of principal .
Largest 10 bondholders include Linden Advisors LP ($164M of principal), Invesco Ltd. ($59.8M of principal), CAMDEN ASSET MANAGEMENT L P /CA ($56.7M of principal), WOLVERINE ASSET MANAGEMENT LLC ($56.3M of principal), ZAZOVE ASSOCIATES LLC ($42.6M of principal), ZAZOVE ASSOCIATES LLC ($42.6M of principal), FRANKLIN RESOURCES INC ($37.4M of principal), Calamos Advisors LLC ($22.5M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($21.7M of principal), and WELLS FARGO & COMPANY/MN ($20.6M of principal).
This table shows the top 49 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.